Related Experiment Video
Updated: Mar 19, 2026

A Quantitative Detection Method for MicroRNAs in the Kidney of an Ischemic Kidney Injury Mouse Model
Published on: September 11, 2020
MicroRNAs in Pathogenesis of Acute Kidney Injury
Zhiwen Liu1, Shixuan Wang, Qing-Sheng Mi
1Department of Nephrology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Abstract:
MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression mainly by repressing their target gene translation. A large spectrum of human diseases is associated with significant changes in miRNAs. Many miRNAs are induced in diseases, whereas some others are downregulated. The significance of miRNAs has been demonstrated in renal development and physiology, and in major kidney diseases such as acute kidney injury (AKI). Recent studies have further implicated specific miRNAs in the pathogenesis of AKI. miRNAs also have the potential to become new diagnostic biomarkers of AKI. Further investigation will identify the key pathogenic miRNAs in various types of AKI and test miRNA-based therapeutics and diagnosis. © 2016 S. Karger AG, Basel.
Insights
MicroRNAs (miRNAs) regulate gene expression and are altered in diseases, including acute kidney injury (AKI). Specific miRNAs are implicated in AKI pathogenesis and show potential as diagnostic biomarkers.
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Background:
- MicroRNAs (miRNAs) are small non-coding RNAs regulating gene expression post-transcriptionally.
- Aberrant miRNA expression is linked to various human diseases.
- miRNAs play crucial roles in renal physiology and development.
Purpose of the Study:
- To review the role of miRNAs in the pathogenesis of acute kidney injury (AKI).
- To explore the potential of miRNAs as diagnostic biomarkers for AKI.
- To highlight future directions in miRNA-based AKI research and therapeutics.
Main Methods:
- Literature review of recent studies on miRNAs in AKI.
- Analysis of miRNA dysregulation in kidney disease models and patients.
- Discussion of diagnostic and therapeutic potential of miRNAs.
Main Results:
- Specific miRNAs are significantly altered in AKI, contributing to its pathogenesis.
- miRNA expression profiles can serve as potential biomarkers for AKI diagnosis.
- miRNA-based interventions are emerging as a therapeutic strategy for AKI.
Conclusions:
- miRNAs are key players in AKI development and progression.
- Targeting miRNAs offers a promising avenue for AKI diagnosis and treatment.
- Further research is needed to fully elucidate miRNA functions in AKI and develop clinical applications.
Related Concept Videos
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury I: Introduction
Nephrons
Acute Pyelonephritis I: Introduction
Acute Kidney Injury III: Clinical Manifestations

